Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2019/05/019386
CTRI/2019/05/019386Suspended未知

An open label crossover study to estimate Glycemic index of Murchit Atta as compare to Regular Atta in a patients with Type 2 Diabetes mellitus

Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Suspended
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Patients of either sex in the age group between 18 to 50 years (Both Inclusive)
  • •2. Willing to provide written informed consent
  • •3. Patients diagnosed to be suffering from Type 2 diabetes mellitus taking oral hypoglycemic drugs and with blood sugar stabilized within normal range(Fasting sugar level < 110 mg/dl and Postprandial sugar level < 140 mg/dl )

Exclusion Criteria

  • •1.Patients of either sex having age below 18 and above 50
  • •2. Not willing to provide written inform consent
  • •3. Patients diagnosed as Type 1 diabetes mellitus
  • •4. Patients with past 30 days history
  • •A) Any major illness that required hospitalization
  • •B) acute exacerbation of any ongoing chronic medical illness e.g. Congestive cardiac failure Hepatitis Hypotensive episodes HIV etc Medications requiring change of doses for treatment of the chronic illness
  • •5. Patients suffering from severe cardiac renal liver or any other organ impairment.
  • •6. History of seizures epilepsy or any neurological disorders
  • •7. Recent history of dehydration from diarrhoea vomiting or any other reason within a period of 24 hours prior to enrolment in the study
  • •8. Patient with any history of food allergy or any ingredient of investigational Murchit atta
  • •9. Pregnant or lactating females

Investigators

Sponsor
Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital

Similar Trials

Not yet recruiting
Not Applicable
Estimate glycemic index of Murchit atta
CTRI/2019/04/018362Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital
Completed
Not Applicable
Open-label cross-over study to evaluate the amount of residual inhaled corticosteroid (hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP) and fluticasone propionate dry powder inhaler (FP-DPI)) in the mouths of elderly asthmatic patients after each inhalatioAsthma
JPRN-UMIN000001323JA Gifu Kouseiren Tohno-Kousei Hospital22
Completed
Not Applicable
An open label, crossover study to investigate the safety and tolerability of Sifrol® (pramipexole) (Boehringer Ingelheim) prolonged release tablets in order to establish the maximum tolerable dose and to assess bioequivalence of Pramipexole prolonged release tablets (Synthon B.V.) compared to Sifrol® prolonged release tablets (Boehringer Ingelheim) in healthy subjects in steady-state conditions10042258parkinson's disease
NL-OMON36833Synthon B.V52
Completed
Not Applicable
A study for measurement of Glycemic Index (GI) of two kinds of foods in adult males and females
JPRN-UMIN000037071TTC Co., Ltd.12
Recruiting
Unknown
A single-center open-label crossover study of the clinical utility and safety of the BV-UFC system of the DCS-200Si dialysis monitorPatients undergoing hemodialysishemodialysisD006435
JPRN-jRCT1062230034Hamada Shintaro20